Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
463-06-001.
The Value of Gadoxetate Disodium-Enhanced MRI Habitat Imaging in Preoperative Prediction of Proliferative HCC
Impact: The nomogram model based on gadoxetate disodium-enhanced MRI habitat imaging demonstrates potential for predicting proliferative hepatocellular carcinoma and exhibits favorable capability for prognostic risk stratification.
|
||
|
463-06-002.
DCE-MRI Morphometric Assessment Predicts Chemotherapy Response in Colorectal Liver Metastasis
Impact: This study reveals the potential role of morphometric features in predicting chemotherapy response in CRLM, providing a practical and effective tool for clinical decision-making.
|
||
|
463-06-003.
Multiparametric 18F-FDG PET/MRI Reveals Intratumoral Heterogeneity for Differentiating Benign and Malignant Solitary Pulmonar
Impact: Multiparametric 18F-FDG PET/MRI habitat imaging enables non-invasive differentiation of benign and malignant solitary pulmonary lesions by quantifying intratumoral spatial heterogeneity. This approach reveals distinct subregional patterns and provides novel imaging biomarkers with potential clinical utility for precision diagnosis and management.
|
||
|
463-06-004.
Habitat analysis and peritumoral radiomics for predicting castration resistance in prostate cancer patients
Impact: Habitat analysis can predict the likelihood of CRPC development in PCa patients by resolving intratumoral heterogeneity. The peritumoral radiomics model holds independent predictive value for CRPC, and integrating peritumoral radiomic features can further enhance model performance.
|
||
|
463-06-005.
The value of foundation model-driven multiomics for predicting platinum resistance in HGSOC patients
Impact:
|
||
|
463-06-006.
Multiparametric MRI in the Discrimination of Progression from Atypical Endometrial Hyperplasia to Stage IA Endometrial Cancer
Impact: This study confirms the critical role of multiparametric MRI in differentiating AH from Stage IA EC, paving the way for a reliable, non-invasive approach to clinical diagnosis.
|
||
|
463-06-007.
Noninvasive Assessment of Bladder Cancer Staging and Grading Using Continuous-Time Random Walk-Based Habitat Analysis
Impact:
Our results show that CTRW-derived parameters, particularly in Habitat 2, effectively distinguish staging and grading subgroups. A combined model incorporating imaging and clinical factors achieved strong predictive performance, highlighting its potential as a noninvasive diagnostic tool. |
||
|
463-06-008.
Automated Lesion Detection of Deep Learning-based Phase Corrected Single-Shot rFOV Diffusion Images of the Prostate
Impact: DL Phase Correction improves the signal-to-noise ratio and IQ of prostate
DWI over current commercial DL reconstructions, while showing compatibility
with an investigational automated prostate lesion detection tool.
|
||
|
463-06-009.
Radiomic feature analyses reveal imaging biomarkers correlated with PI-RADS lesion classification in prostate cancer MRI.
Impact: Radiomic features calculated on clinical multiparametric MRI strongly correlate with PI-RADS classifications. These features may provide quantitative biomarkers to aid diagnostic confidence for indeterminate PI-RADS lesions and reduce inter-rater variability.
|
||
|
463-06-010.
A Biparametric MRI-based Deep Transfer Learning and Radiomics Model for Diagnosing Clinically Significant Prostate Cancer
Impact: This study provides a critical foundation for optimizing prostate biopsy decisions. It can potentially reduce unnecessary procedures and improve patient management, demonstrating significant promise for clinical translation.
|
||
|
463-06-011.
MRI in Diagnosing Lumbar Spine Chordoma: Insights from a Low-Resource Environment
Impact: This case demonstrates how MRI can act as a surrogate diagnostic adjunct in settings with limited access to histopathology. By guiding early surgical planning and multidisciplinary care for spinal chordoma, MRI enhances clinical decision-making and promotes equitable cancer management.
|
© 2026 International Society for Magnetic Resonance in Medicine